Drug intelligence / Profile preview

ectericid

Development stage
Unknown
Lead developer
Farmstandart-Biolik
Modality
Small Molecules
Administration
Topical
01

Overview

Ectericid (Ekterytsyd) is an antiseptic and disinfectant agent of natural origin, derived from the water-soluble oxidation products of fish oil (containing a mixture of carbonyl compounds, peroxides, and aldehydes) in an isotonic sodium chloride solution. Developed and manufactured by Biolik Pharma (formerly Farmstandart-Biolik) in Ukraine, Ectericid exhibits broad-spectrum antibacterial activity against pyogenic microflora, including Pseudomonas aeruginosa, Escherichia coli, Proteus spp., and Staphylococcus aureus (including antibiotic-resistant strains). It is primarily used topically for the treatment of postoperative and traumatic wounds complicated by purulent infections, slow-healing wounds, furuncles, carbuncles, fistulous forms of osteomyelitis, burns, and trophic ulcers with suppuration.

Brand names
EctericidEkteritsidEkterytsydЕктерицид
Other names
Ectericidumproducts of fish oil oxidation

Beyond the preview

Go deeper on ectericid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ectericid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call